Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Gross Profit (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Gross Profit for 10 consecutive years, with $45.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 26.83% to $45.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $172.7 million, a 16.19% increase, with the full-year FY2025 number at $172.7 million, up 16.19% from a year prior.
  • Gross Profit was $45.1 million for Q4 2025 at Orthopediatrics, roughly flat from $45.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $45.3 million in Q3 2025 to a low of $16.3 million in Q1 2021.
  • A 5-year average of $29.8 million and a median of $28.4 million in 2023 define the central range for Gross Profit.
  • Biggest YoY gain for Gross Profit was 103.19% in 2021; the steepest drop was 5.19% in 2021.
  • Orthopediatrics' Gross Profit stood at $18.1 million in 2021, then increased by 17.38% to $21.2 million in 2022, then increased by 25.87% to $26.7 million in 2023, then soared by 33.13% to $35.6 million in 2024, then grew by 26.83% to $45.1 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Gross Profit are $45.1 million (Q4 2025), $45.3 million (Q3 2025), and $44.0 million (Q2 2025).